Table 1 |
|||
|
Characteristics of patients |
|||
| Cohort 1 (n = 20)* |
Cohort 2 (n = 64)* |
Cohort 3 (n = 33)* |
|
|
|
|||
| Sex |
14 male, 6 female |
44 male, 20 female |
19 male, 14 female |
| Age in years† |
3.5 (0.4-12.6) |
2.1 (0.35-15.6) |
1.7 (0.1-4.5) |
| Coronary artery status‡ |
11 N, 7 D, 2 A |
33 N, 22 D, 9 A |
26 N, 3 D, 4 A |
| IVIG response§ |
14 R, 4 NR |
45 R, 8 NR |
22 R, 11 NR |
| Illness day, acute sample† |
Day 6 (4-12) |
Day 6 (2-14) |
Day 5 (3-7) |
| Illness day, subacute sample† |
Day 20 (12-24)¶ |
NA |
NA |
| Illness day, convalescent sample† |
Day 47 (32-64)¶ |
NA |
NA |
|
|
|||
|
*Seven individuals were in both cohort 1 and cohort 2; three additional individuals were in both cohort 1 and cohort 3. †Data presented as median (range). ‡Arterial diameter determined by echocardiogram. N, normal; D, dilated; A; aneurysm. §R, IVIG responder; NR, IVIG non-responder. Two patients in cohort 1 and 11 in cohort 2 were treated with IVIG after illness day 10 and excluded from analysis of IVIG response. ¶Additional samples were obtained from three patients less than 48 h after treatment with IVIG on illness days 7, 8, and 13; one additional sample was obtained from a fourth patient at a 1-year follow-up. NA, not applicable. |
|||
|
Popper et al. Genome Biology 2007 8:R261 doi:10.1186/gb-2007-8-12-r261 |
|||
